New strategies in the management of acute coronary syndromes.


Journal Article (Review)

Advances in the understanding of acute coronary syndromes have occurred rapidly in the last 5 years and have dramatically changed the way patients are evaluated, diagnosed, and managed. Medical advances, such as antiplatelet and antithrombin agents and growing databases on interventional outcomes have created a new world of therapeutic options for the spectrum of ischemic heart disease. As more options become available, nurses are under increasing pressure to stay abreast of what these options have to offer patients, and which patients benefit most from each therapeutic approach. The purpose of this article is to review the newest therapies for acute coronary syndromes, including GP IIb/IIIa inhibitors, low molecular weight heparins, and direct thrombin inhibitors, and discuss indications and contraindications for each of these therapies. Changes in diagnostic approach using troponin T and I are also presented.

Full Text

Duke Authors

Cited Authors

  • Fullwood, J; Butler, G; Smith, T; Cox, M; Bride, W; Mostaghimi, Z; Cook, PS; Granger, BB

Published Date

  • December 2000

Published In

Volume / Issue

  • 35 / 4

Start / End Page

  • 877 - 895

PubMed ID

  • 11072276

Pubmed Central ID

  • 11072276

Electronic International Standard Serial Number (EISSN)

  • 1558-1357

International Standard Serial Number (ISSN)

  • 0029-6465


  • eng